CN103751659B - 一种用于治疗冠心病的中药制剂及制备方法 - Google Patents
一种用于治疗冠心病的中药制剂及制备方法 Download PDFInfo
- Publication number
- CN103751659B CN103751659B CN201410037417.5A CN201410037417A CN103751659B CN 103751659 B CN103751659 B CN 103751659B CN 201410037417 A CN201410037417 A CN 201410037417A CN 103751659 B CN103751659 B CN 103751659B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine preparation
- heart disease
- coronary heart
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims abstract description 51
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 42
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 14
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 14
- 241000237524 Mytilus Species 0.000 claims abstract description 14
- 239000010135 fructus aurantii immaturus Substances 0.000 claims abstract description 14
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 claims abstract description 13
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 13
- 241000219780 Pueraria Species 0.000 claims abstract description 13
- 241000522620 Scorpio Species 0.000 claims abstract description 13
- 241001646982 Thamnolia vermicularis Species 0.000 claims abstract description 13
- 239000004615 ingredient Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 239000009490 scorpio Substances 0.000 claims abstract description 10
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims description 21
- 238000005202 decontamination Methods 0.000 claims description 12
- 230000003588 decontaminative effect Effects 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000004570 mortar (masonry) Substances 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- -1 boil 1-2 hour Substances 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 21
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 14
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 13
- 206010020772 Hypertension Diseases 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 230000007812 deficiency Effects 0.000 abstract description 7
- 210000004351 coronary vessel Anatomy 0.000 abstract description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 5
- 230000002107 myocardial effect Effects 0.000 abstract description 4
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 3
- 239000012567 medical material Substances 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000036284 oxygen consumption Effects 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 3
- 241000218628 Ginkgo Species 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 10
- 210000000038 chest Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000007443 Neurasthenia Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000004217 heart function Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 208000031225 myocardial ischemia Diseases 0.000 description 4
- 206010008479 Chest Pain Diseases 0.000 description 3
- 239000003390 Chinese drug Substances 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010019280 Heart failures Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 230000003143 atherosclerotic effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019345 Heat stroke Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010042434 Sudden death Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- RYAHJFGVOCZDEI-UFFNCVEVSA-N Dendrobine Chemical compound C([C@H]1CC[C@@H]2[C@@]31C)N(C)[C@@H]3[C@H]1[C@@H](C(C)C)[C@@H]2C(=O)O1 RYAHJFGVOCZDEI-UFFNCVEVSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010048858 Ischaemic cardiomyopathy Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000002586 coronary angiography Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- RYAHJFGVOCZDEI-CZKZLRAZSA-N dendrobine Natural products O=C1O[C@@H]2[C@H](C(C)C)[C@H]1[C@H]1[C@@]3(C)[C@@H]2N(C)C[C@H]3CC1 RYAHJFGVOCZDEI-CZKZLRAZSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000013146 percutaneous coronary intervention Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 210000002097 psoas muscle Anatomy 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 239000002795 scorpion venom Substances 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410037417.5A CN103751659B (zh) | 2014-01-20 | 2014-01-20 | 一种用于治疗冠心病的中药制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410037417.5A CN103751659B (zh) | 2014-01-20 | 2014-01-20 | 一种用于治疗冠心病的中药制剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103751659A CN103751659A (zh) | 2014-04-30 |
CN103751659B true CN103751659B (zh) | 2016-06-08 |
Family
ID=50519086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410037417.5A Expired - Fee Related CN103751659B (zh) | 2014-01-20 | 2014-01-20 | 一种用于治疗冠心病的中药制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103751659B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104840929A (zh) * | 2015-06-02 | 2015-08-19 | 夏征梅 | 一种治疗冠心病的中药蜜丸 |
CN105477437A (zh) * | 2016-01-26 | 2016-04-13 | 娄明晓 | 一种治疗缺血性心肌病的中药及制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1305844A (zh) * | 2001-01-14 | 2001-08-01 | 刘红 | 用于治疗充血性心力衰竭的药物 |
CN1334121A (zh) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | 一种通心络药物组合物及应用 |
-
2014
- 2014-01-20 CN CN201410037417.5A patent/CN103751659B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1305844A (zh) * | 2001-01-14 | 2001-08-01 | 刘红 | 用于治疗充血性心力衰竭的药物 |
CN1334121A (zh) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | 一种通心络药物组合物及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103751659A (zh) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103751482B (zh) | 一种用于治疗产后腹痛的药物及制备方法 | |
CN103736072B (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
CN103919910B (zh) | 一种治疗冠心病的药物 | |
CN103751659B (zh) | 一种用于治疗冠心病的中药制剂及制备方法 | |
CN104013919A (zh) | 一种治疗心绞痛的中药 | |
CN103610936B (zh) | 一种治疗冠心病的中药制剂及制备方法 | |
CN104225200A (zh) | 一种治疗饮凌心肺型心源性哮喘的中药及制备方法 | |
CN105833172A (zh) | 用于治疗无症状性心肌缺血的中药冲剂及制备方法 | |
CN105687738A (zh) | 一种用于治疗顽固性咳嗽的中药冲剂及制备方法 | |
CN104338052A (zh) | 治疗脑血栓的中药配方 | |
CN104117020A (zh) | 一种治疗心房颤动的中药配方 | |
CN103550713A (zh) | 一种治疗高血压的中药 | |
CN103720870B (zh) | 一种治疗心肌炎症的中药制剂及制备方法 | |
CN103860990B (zh) | 冠心病活血通络散剂及制备方法 | |
CN103721028B (zh) | 一种治疗心绞痛的药物及制备方法 | |
CN106692858A (zh) | 一种治疗胎动不安的药物及其制备方法 | |
CN105477171A (zh) | 一种用于治疗高脂血症的胶囊及制备方法 | |
CN105770520A (zh) | 一种用于治疗冠心病的药物制剂及其用途 | |
CN103893496A (zh) | 一种治疗心绞痛的中药制剂及制备方法 | |
CN105125786A (zh) | 一种用于治疗乳腺增生的中药制剂及制备方法 | |
CN103920047A (zh) | 一种治疗胃出血的中药制剂及制备方法 | |
CN103845626A (zh) | 一种治疗精神分裂症的药物及制备方法 | |
CN105726813A (zh) | 治疗冠心病的中药制剂及其制备方法 | |
CN102764326B (zh) | 一种治疗冠心病的中药组合物 | |
CN103520644A (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Ma Xipeng Inventor after: Zhang Wenjing Inventor after: Sun Fangli Inventor before: Han Kai Inventor before: Zhou Fengyun Inventor before: Zhao Jing |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160503 Address after: 272000 Beijiao city of Jining province Shandong nine meters Gu Dui tuberculosis prevention and control in Jining City Applicant after: Ma Xipeng Address before: No. 308 people's Hospital of Zhangqiu City, Ji'nan City, Mingshui Huiquan road 250200 Shandong city of Zhangqiu Province Applicant before: Han Kai |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wu Wenguang Inventor before: Ma Xipeng Inventor before: Zhang Wenjing Inventor before: Sun Fangli |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170829 Address after: 063000 No. 11, No. 7 row, Hangu Han Fengzhen soap Village, Lunan District, Hebei, Tangshan City Patentee after: Wu Wenguang Address before: 272000 Beijiao city of Jining province Shandong nine meters Gu Dui tuberculosis prevention and control in Jining City Patentee before: Ma Xipeng |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160608 Termination date: 20180120 |